Evidence map›Paper›PMID 35966510›Full record

ReviewInternational journal of general medicine2022

Management of Subacute Thyroiditis - A Systematic Review of Current Treatment Protocols.

Ishita Ray, Brandon D'Souza, Pallab Sarker, Pawan Agarwal

Open access · goldAbstract readReview
In one paragraph

Review in International journal of general medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. How to manage subacute thyroiditis.Drugs in context · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Post-dengue subacute thyroiditis in a Peruvian woman: case report and literature review.Revista peruana de medicina experimental y salud publica · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Endocrine diseases associated with COVID-19 vaccination: case report.Revista peruana de medicina experimental y salud publica
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Ishita RayDepartment of Medicine, Mahatma Gandhi Memorial Medical College, Indore, India.ORCID 0000-0001-8250-535X
Brandon D'SouzaDepartment of Medicine, Dr. D.Y. Patil Medical College, Pimpri-Chinchwad, India.
Pallab SarkerDepartment of Medicine, Sher E Bangla Medical College, Barisal City, Bangladesh.ORCID 0000-0003-2388-4155
Pawan AgarwalDepartment of Surgery, Netaji Subhash Chandra Bose Medical College Jabalpur, Jabalpur, India.
Dr. D. Y. Patil Medical College, Hospital and Research Centre · INMahatma Gandhi Memorial Medical College · INNetaji Subhash Chandra Bose Medical College · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This systematic review endeavors to find an effective treatment protocol for subacute thyroiditis (SAT) to minimize side effects, recurrence and long-term hypothyroidism. Materials and Methods: We analyzed available original studies on treatment protocols for SAT. A thorough literature search was performed on the following online databases PubMed, Cochrane library nd Google Scholar using appropriate keywords for choosing relevant articles. Two reviewers assessed the methodological quality of selected articles independently using a critical appraisal instrument. The results were analyzed and synthesized qualitatively using the level of evidence method. Results: The literature search retrieved a total of 460 publications after abstract screening; out of which 36 articles met the inclusion criteria. After full text screening, 23 articles were further excluded as they were focusing on aspects of SAT other than management, the remaining 15 articles were investigated for both reliability and validity. Thirteen studies provided low-quality evidence, and two randomized control trials (RCT) provided a high quality of evidence. Steroid therapy was found to be the most effective for moderate to severe SAT and provided relief from acute symptoms but was found to not be a risk factor for recurrence. Low initial doses of steroid (15 mg) were preferred over high initial dosage (30-40 mg). Furthermore, a look into the mode of steroid delivery (RCT) revealed that intrathyroidal steroid therapy can potentially become a safer and faster mode of therapy. The duration of tapering was found to be of significance as a short tapering period was linked with greater recurrence rates. Conclusion: Low initial doses of steroid along with an extended tapering period may help lower recurrence rates; also, intrathyroidal steroid injections are potentially a better alternative to oral prednisone (PSN) with regard to safety and speed of action. However, the evidence is of moderate quality and further investigation is required.

Indexed as

de Quervain thyroiditisNSAIDSpainful thyroiditisrecurrencesteroidsubacute thyroiditis

Identifiers

PMID35966510
PMCPMC9365321
OpenAlexW4290005564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.